CR
CRISPR Therapeutics
CRSP · NASDAQ
$54.78 +0.61% (+$0.33)
1M +4.26%
Market Cap $5.28B
P/E Ratio -
Div. Yield -
ROE 24.39%
Bulios Fair Price
$44.59
18.6% downside
Trenutna cena
$54.78
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CRSP trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
33 /100
Expensive P/S 394.52x
P/B 3.03x
P/E N/A
Growth
84 /100
Growing Rev. growth 100.42%
Book val. growth 0.82%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 1,534.39%
Net margin 3,368.72%
FCF margin 3,589.65%
Quality
0 /100
Poor ROIC 21.11%
ROE 24.39%
Asset turnover 0.01x
Debt
92 /100
Low Debt/Equity 0.45x
Current ratio 17.85x
Int. coverage N/A
Stability
4 /100
Unstable Beta 1.74x
Rev. volatility 48,989.70%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRSP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Samarth Kulkarni
Employees
393
Headquarters
Zug
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report